Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 1
1955 3
1956 2
1957 1
1958 1
1959 3
1961 3
1962 3
1963 1
1964 1
1965 1
1966 1
1968 1
1970 1
1971 2
1975 1
1976 1
1977 1
1978 1
1979 3
1980 3
1981 6
1982 5
1983 7
1984 1
1985 3
1986 9
1987 3
1988 4
1989 2
1990 5
1991 2
1992 10
1993 10
1994 6
1995 7
1996 9
1997 7
1998 10
1999 5
2000 8
2001 3
2002 6
2003 9
2004 4
2005 18
2006 17
2007 15
2008 14
2009 17
2010 21
2011 20
2012 9
2013 1
2014 5
2015 2
2016 6
2017 3
2018 6
2019 6
2020 5
2021 9
2022 7
2023 4
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

341 results

Results by year

Filters applied: . Clear all
Page 1
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kopyltsov E, Park CH, Alekseev B, Montesa-Pino Á, Ye D, Parnis F, Cruz F, Tammela TLJ, Suzuki H, Utriainen T, Fu C, Uemura M, Méndez-Vidal MJ, Maughan BL, Joensuu H, Thiele S, Li R, Kuss I, Tombal B; ARASENS Trial Investigators. Smith MR, et al. N Engl J Med. 2022 Mar 24;386(12):1132-1142. doi: 10.1056/NEJMoa2119115. Epub 2022 Feb 17. N Engl J Med. 2022. PMID: 35179323 Free PMC article. Clinical Trial.
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer.
Sternberg CN, Fizazi K, Saad F, Shore ND, De Giorgi U, Penson DF, Ferreira U, Efstathiou E, Madziarska K, Kolinsky MP, Cubero DIG, Noerby B, Zohren F, Lin X, Modelska K, Sugg J, Steinberg J, Hussain M; PROSPER Investigators. Sternberg CN, et al. N Engl J Med. 2020 Jun 4;382(23):2197-2206. doi: 10.1056/NEJMoa2003892. Epub 2020 May 29. N Engl J Med. 2020. PMID: 32469184 Clinical Trial.
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators. Miles D, et al. Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2. Ann Oncol. 2021. PMID: 34224826 Free article. Clinical Trial.
Cross-cultural color-odor associations.
Levitan CA, Ren J, Woods AT, Boesveldt S, Chan JS, McKenzie KJ, Dodson M, Levin JA, Leong CX, van den Bosch JJ. Levitan CA, et al. Among authors: van den bosch jj. PLoS One. 2014 Jul 9;9(7):e101651. doi: 10.1371/journal.pone.0101651. eCollection 2014. PLoS One. 2014. PMID: 25007343 Free PMC article.
One hundred years of EEG for brain and behaviour research.
Mushtaq F, Welke D, Gallagher A, Pavlov YG, Kouara L, Bosch-Bayard J, van den Bosch JJF, Arvaneh M, Bland AR, Chaumon M, Borck C, He X, Luck SJ, Machizawa MG, Pernet C, Puce A, Segalowitz SJ, Rogers C, Awais M, Babiloni C, Bailey NW, Baillet S, Bendall RCA, Brady D, Bringas-Vega ML, Busch NA, Calzada-Reyes A, Chatard A, Clayson PE, Cohen MX, Cole J, Constant M, Corneyllie A, Coyle D, Cruse D, Delis I, Delorme A, Fair D, Falk TH, Gamer M, Ganis G, Gloy K, Gregory S, Hassall CD, Hiley KE, Ivry RB, Jerbi K, Jenkins M, Kaiser J, Keil A, Knight RT, Kochen S, Kotchoubey B, Krigolson OE, Langer N, Liesefeld HR, Lippé S, London RE, MacNamara A, Makeig S, Marinovic W, Martínez-Montes E, Marzuki AA, Mathew RK, Michel C, Millán JDR, Mon-Williams M, Morales-Chacón L, Naar R, Nilsonne G, Niso G, Nyhus E, Oostenveld R, Paul K, Paulus W, Pfabigan DM, Pourtois G, Rampp S, Rausch M, Robbins K, Rossini PM, Ruzzoli M, Schmidt B, Senderecka M, Srinivasan N, Stegmann Y, Thompson PM, Valdes-Sosa M, van der Molen MJW, Veniero D, Verona E, Voytek B, Yao D, Evans AC, Valdes-Sosa P. Mushtaq F, et al. Among authors: van den bosch jjf. Nat Hum Behav. 2024 Aug;8(8):1437-1443. doi: 10.1038/s41562-024-01941-5. Nat Hum Behav. 2024. PMID: 39174725 Free article. No abstract available.
Ribonuclease-sensitive ribosomal vaccines.
Gonggrijp R, Antonissen AC, van den Bosch JF, van Boven CP. Gonggrijp R, et al. Among authors: van den bosch jf. Antonie Van Leeuwenhoek. 1984;50(5-6):763-74. doi: 10.1007/BF02386239. Antonie Van Leeuwenhoek. 1984. PMID: 6084981
Amaurosis congenita (Leber).
SCHAPPERT-KIMMIJSER J, HENKES HE, VAN DEN BOSCH J. SCHAPPERT-KIMMIJSER J, et al. Among authors: van den bosch j. AMA Arch Ophthalmol. 1959 Feb;61(2):211-8. doi: 10.1001/archopht.1959.00940090213003. AMA Arch Ophthalmol. 1959. PMID: 13616783 No abstract available.
Corticosteroid treatment in sarcoidosis.
Grutters JC, van den Bosch JM. Grutters JC, et al. Among authors: van den bosch jm. Eur Respir J. 2006 Sep;28(3):627-36. doi: 10.1183/09031936.06.00105805. Eur Respir J. 2006. PMID: 16946094 Free article. Review.
Predicting prognosis in idiopathic pulmonary fibrosis.
Barlo NP, van Moorsel CH, van den Bosch JM, Grutters JC. Barlo NP, et al. Among authors: van den bosch jm. Sarcoidosis Vasc Diffuse Lung Dis. 2010 Jul;27(2):85-95. Sarcoidosis Vasc Diffuse Lung Dis. 2010. PMID: 21319590 Review.
341 results